In the pharmaceutical field, Hederacoside C is widely used in the development of various drugs and clinical treatments due to its well-defined expectorant, bronchodilatory, and anti-inflammatory pharmacological activities. Its main application directions include:
Expectorant Drugs: Hederacoside C's most core pharmaceutical application is as an expectorant for treating cough and phlegm symptoms associated with acute and chronic bronchitis and other respiratory diseases. It stimulates respiratory gland secretion, reduces sputum viscosity, promotes ciliary movement, and makes phlegm easier to expel.
Pediatric Cough Medicines: Due to its good safety profile and natural origin, Hederacoside C is widely used in Europe for treating cough and bronchitis in children. Ivy leaf extract preparations are among the best-selling pediatric over-the-counter cough and expectorant medicines in countries like Germany, often used as adjunctive treatment for acute respiratory infections.
Chronic Obstructive Pulmonary Disease Adjunctive Therapy: Studies indicate that Hederacoside C may help improve lung function and quality of life in COPD patients, reducing airway inflammation through its anti-inflammatory and antioxidant mechanisms.
Anti-Inflammatory Drugs: Hederacoside C has certain anti-inflammatory activity, inhibiting the production and release of various inflammatory factors, and is used in the adjunctive treatment of respiratory inflammatory diseases.
Charissa Liu
www.staherb.cn
Whatsapp:+86-18973140712
Tel/Mobile/Wechat: +86-13657431735
Email:sales05@staherb.cn
